Human Xtensions (Israel) Today
| HUMX Stock | ILA 27.20 2.50 8.42% |
Performance0 of 100
| Odds Of DistressOver 59
|
Human Xtensions is trading at 27.20 as of the 2nd of December 2024, a 8.42 percent decrease since the beginning of the trading day. The stock's open price was 29.7. Human Xtensions has over 59 % chance of experiencing financial distress in the next 2 years of operation and has generated negative returns for investors over the last 90 days. Equity ratings for Human Xtensions are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 13th of December 2022 and ending today, the 2nd of December 2024. Click here to learn more.
It offers HandX, a handheld medical device for use in laparoscopic procedures. The company was founded in 2012 and is based in Netanya, Israel. HUMAN XTENSIONS operates under Medical Devices classification in Israel and is traded on Tel Aviv Stock Exchange. It employs 58 people. The company has 26.76 M outstanding shares. More on Human Xtensions
Moving together with Human Stock
Moving against Human Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Human Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Human Xtensions' investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Human Xtensions or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Business Concentration | Medical Devices, Healthcare (View all Sectors) |
Human Xtensions (HUMX) is traded on Tel Aviv Stock Exchange in Israel and employs 72 people. The company currently falls under 'Micro-Cap' category with a current market capitalization of 28.63 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Human Xtensions's market, we take the total number of its shares issued and multiply it by Human Xtensions's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Human Xtensions operates under Healthcare sector and is part of Medical Devices industry. The entity has 26.76 M outstanding shares.
Human Xtensions has accumulated about 148.31 M in cash with (27.26 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.56.
Check Human Xtensions Probability Of Bankruptcy
Ownership AllocationHuman Xtensions has a total of 26.76 Million outstanding shares. Human Xtensions secures significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Human Ownership Details
Human Xtensions Risk Profiles
Although Human Xtensions' alpha and beta are two of the key measurements used to evaluate Human Xtensions' performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 4.14 | |||
| Standard Deviation | 7.42 | |||
| Variance | 55.1 | |||
| Risk Adjusted Performance | (0.01) |
Human Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Human Xtensions without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Fundamentals Comparison Now
Fundamentals ComparisonCompare fundamentals across multiple equities to find investing opportunities |
| All Next | Launch Module |
Human Xtensions Corporate Management
Elected by the shareholders, the Human Xtensions' board of directors comprises two types of representatives: Human Xtensions inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Human. The board's role is to monitor Human Xtensions' management team and ensure that shareholders' interests are well served. Human Xtensions' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Human Xtensions' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Asaf Stolovy | Chief Officer | Profile | |
| Amir MD | Chief Officer | Profile | |
| Barak Klein | Chief Officer | Profile | |
| Alon Heth | VP Sales | Profile | |
| Tami Frenkel | CoFounder Director | Profile | |
| Ronen Castro | Chief Officer | Profile | |
| Hagar Lisser | Human Director | Profile |
Other Information on Investing in Human Stock
Human Xtensions financial ratios help investors to determine whether Human Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Human with respect to the benefits of owning Human Xtensions security.